Loading
Total declarations
Companies
▲ Purchases (0 ops.)
▼ Sales (0 ops.)
Latest filing published 03 Mar 2026 for Lexicon Pharmaceuticals, INC..
Insider track record
Disclosed buys
0
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Lisa DeFrancesco: trading record in brief
Filings by Lisa DeFrancesco span 2 companies, the busiest being Lexicon Pharmaceuticals, Inc. and Intercept Pharmaceuticals, Inc. Over a trading history stretching from 1 September 2021 to 28 February 2026, the count stands at 8 filings.
No open-market purchase or sale appears among the filings, only grants, plan transactions and other operations. Because grants and exercises are largely decided by remuneration plans, they are not counted as purchases here.
On 3 March 2026 came the latest disclosure, a share grant for €93k in Lexicon Pharmaceuticals, Inc. The median gap between a trade and its publication by SEC (Form 4) is 3 days. The legal deadline for a Form 4 is two business days after the transaction. Source: insider filings from SEC (Form 4). Past trades are no guide to future returns.
Companies and markets linked to Lisa DeFrancesco
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations5 total
24,674 sharesCommon StockSEC:0001062822-26-000037:0
24,673 sharesCommon StockSEC:0001127602-25-007527:0
542 shares@ US$16.2945.2% of flowCommon StockSEC:0001104659-22-000929:0
204 shares@ US$14.8515.2% of flowCommon StockSEC:0001104659-21-122561:0
538 shares@ US$15.0539.6% of flowCommon StockSEC:0001104659-21-113041:0
5 of 5 declarations
